A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Tzu-Fei WangBryce A. Kerlin

Abstract

Venous thromboembolism (VTE) is the third most common cardiovascular disease and optimizing treatment is essential. In this single-center pilot study, we sought to investigate the effects of statins in addition to anticoagulation in patients with acute VTE. We enrolled patients over 18 with an acute proximal lower extremity deep vein thrombosis with or without pulmonary embolism. Patients were randomized to anticoagulation alone (with either warfarin or rivaroxaban) or anticoagulation and atorvastatin 40 mg daily and followed for 9 months. The primary objective was to determine if adjunct atorvastatin reduced thrombin generation, measured by endogenous thrombin potential and/or peak thrombin concentration. Secondary endpoints included recurrent VTE, arterial thrombosis, bleeding events, lipidomic profiles, and symptoms of post thrombotic syndrome. A total of 21 patients were enrolled (11 anticoagulation only and 10 anticoagulation and atorvastatin) over 3.5 years. Endogenous thrombin potential or peak thrombin was not significantly recued with the addition of atorvastatin. Atorvastatin did significantly reduce the mean LDLs at 3 months, without reduction of either d-dimer or high-sensitivity-C reactive protein. Given the low re...Continue Reading

Associated Clinical Trials

Jan 6, 2015·Tzu-Fei Wang, Tzu-Fei Wang

References

Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Aug 3, 2001·Archives of Internal Medicine·J G RayA Laupacis
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·A SquizzatoW Ageno
Dec 19, 2007·Circulation·Walter AgenoPieter W Kamphuisen
May 10, 2008·Journal of Thrombosis and Haemostasis : JTH·S R KahnJ S Ginsberg
Nov 28, 2008·Journal of Thrombosis and Haemostasis : JTH·A S RamcharanC J M Doggen
Jan 30, 2009·Journal of Thrombosis and Haemostasis : JTH·S R KahnUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Mar 31, 2009·The New England Journal of Medicine·Robert J GlynnPaul M Ridker
May 7, 2010·Metabolomics : Official Journal of the Metabolomic Society·Rima Kaddurah-DaoukRonald M Krauss
Dec 7, 2010·The New England Journal of Medicine·Rupert BauersachsSebastian Schellong
Nov 15, 2011·Thrombosis Research·Hugo Ten Cate
Jul 3, 2013·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY Investigators
Jun 28, 2014·Circulation·Kirstine Kobberøe SøgaardHenrik Toft Sørensen
Apr 10, 2015·Journal of the American Society of Nephrology : JASN·Bryce A KerlinWilliam E Smoyer
Dec 20, 2018·Journal of Thrombosis and Haemostasis : JTH·Fernanda A OrsiWillem M Lijfering

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved